BIOCHEMISTRY DEPARTMENT



Similar documents
Annex to the Accreditation Certificate D-ML according to DIN EN ISO 15189:2014

Room Temp: 8 Hr. Room Temp: 8Hr. Room Temp: ASAP. Refrigerated (2-8C): 3D. Room Temp: ASAP. Refrigerated (2-8C): 3D

MEDICAL NUTRITION THERAPY (MNT) CLINICAL NUTRITION THERAPY Service Time CPT Code

Georgia Northwestern Technical College Practical Nursing Program CLINICAL DAILY ASSESSMENT WORKSHEET FOR MODULES I-IV STUDENT: CLINICAL INSTRUCTOR:

EXECUTIVE BLOOD WORK PANEL

UNDERSTANDING YOUR LAB TESTS

GENERAL HEALTH SCREEN LAB REPORT. Date of Blood Draw: Time of Blood Draw: Fasting: Yes: X No:

Bio-Rad Laboratories EXTERNAL QUALITY ASSURANCE SERVICES EQAS. External Quality Assurance Services

PROFICIENCY TESTING. Clinical Laboratory Improvement Amendments (CLIA) DOs and DON Ts. Brochure # 8

And Now, Presenting...

Case 2:10-md CJB-SS Document Filed 05/03/12 Page 1 of 5 EXHIBIT 12

A-Z TESTS BIOCHEMISTRY

Clinical Laboratory Parameters for Crl:CD(SD) Rats. March, Information Prepared by Mary L.A. Giknis, Ph.D. Charles B. Clifford, D.V.M., Ph.D.

American Care, Inc SW 211 Street Miami, Florida Member Services:

Adams Memorial Hospital Decatur, Indiana EXPLANATION OF LABORATORY TESTS

Collect and label sample according to standard protocols. Gently invert tube 8-10 times immediately after draw. DO NOT SHAKE. Do not centrifuge.

CHEMISTRY. Updated Monday June 25, CHEMISTRY - BASIC PANEL * may be asked to fast for this test. Range M F 23-29

Hepatitis C. Laboratory Tests and Hepatitis C

Blood Testing Protocols. Disclaimer

SCOPE OF ACCREDITATION ISO 15189:2012. SPECTRA LABORATORY, INC. 525 Sycamore Drive Milpitas, CA Claude O. Burdick, M.D.

Why is a Comprehensive Metabolic Blood Chemistry panel included in the FNHP?

MHDO CompareMaine Updated: 9/17/2015

Acute Pancreatitis. Questionnaire. if yes: amount (cigarettes/day): since when (year): Drug consumption: yes / no if yes: type of drug:. amount:.

FS FSC. Abbreviations in common use. Fluid-stable, ready-to-use reagent. Fluid-stable concentrated reagent for measurement on Olympus AU systems

Pointe Scientific, Inc. Instrument Application

REFERENS RANGES. MEDICAL LABORATORY RAMUS Ltd. HAEMATOLOGY Name of the test Method Reference ranges Hemoglobin Cian-methaemoglobin method

Liver Function Tests. Dr Stephen Butler Paediatric Advance Trainee TDHB

Reference Range: mmol/l (arterial) mmol/l (venous) CPT Code: 83605

KEY CHAPTER 14: BLOOD OBJECTIVES. 1. Describe blood according to its tissue type and major functions.

Liaquat University of Medical & Health Sciences, Jamshoro

Quality Control Products & Services Catalog

The Medical Laboratory Licensing Regulations, 1995

Additional Blood Tests

LABORATORY and PATHOLOGY SERVICES

AU 400 T H E V I S I B L E D I F F E R E N C E A N A L Y S E R S Y S T E M F O R C L I N I C A L C H E M I S T R Y

FULL LABORATORY to HOT LABORATORY DR. DAVID OLEESKY

PHYSICIANS LABORATORY SERVICES ANNUAL NOTICE TO PROVIDERS 2012

Subpart H--Participation in Proficiency Testing for Laboratories Performing Nonwaived Testing

Pointe Scientific, Inc. Instrument Application

COBAS INTEGRA 400 plus

Visual Acuity. Hearing. Height and Weight. Blood Pressure MEASURED VALUE

Including changes in health status since last exam. Known occupational exposures.

International System of Units (SI Units)

LABORATORY MEDICINE CATEGORY LIST. CATEGORY I Laboratories, Vested Interest Laboratory and Hospitals

COMPREHENSIVE DICTIONARY TO STANDARD BLOOD TESTS

cobas c 311 analyzer

Coding and Payment Guide for Laboratory Services. An essential coding, billing, and payment resource for laboratory and pathology services

Implementation Guide

Endocrinology. Values & S.I. Unit Conversion Tables

IMMUNOASSAY CONTROL - LEVEL 1 (IA CONTROL 1)

How to Quickly and Easily Understand Your Blood Tests Without A Medical Degree. The Simplified Patient Reference Guide By Ronald J. Grisanti D.C.

The child with abnormal liver function tests

Clinical Chemistry Line

Proteins. Protein Trivia. Optimizing electrophoresis

OMG my LFT s! How to Interpret and Use Them. OMG my LFT s! OMG my LFT s!

ETHICAL VALUES IN MEDICAL DIAGNOSTICS A CASE STUDY OF NORTH DELHI PATHOLOGY CLINIC

Interpretation of Laboratory Values

IMMUNOASSAY PREMIUM PLUS LEVEL 3 (IA PREMIUM PLUS 3)

Guide to Common Laboratory Tests for Eating Disorder Patients

CTSC Clinical Laboratory. Clinical Laboratory Services CTSC. Clinical & Translational Science Center

Your patient-held blood monitoring record book. Disease-modifying treatment for multiple sclerosis (MS)

DECIPHERING MY MYELOMA LAB RESULTS

Patterns of abnormal LFTs and their differential diagnosis

Albumin. Prothrombin time. Total protein

Human Clinical Study for Free Testosterone & Muscle Mass Boosting

De accreditatie werd uitgereikt aan/ L'accréditation est délivrée à/ The accreditation is granted to/ Die akkreditierung wurde erteilt für:

Bariatric Patients, Nutritional Intervention for

Urinalysis and Body Fluids CRg

Laboratory Services Policy

For people too busy with their present -to worry about their future can now take an Affordable,Fast and Personalised health check up at

Department of Pathology and Laboratory Medicine Capital District Health Authority Nova Scotia

UNIVERSITY OF CONNECTICUT HEALTH CENTER CORRECTIONAL MANAGED HEALTH CARE POLICY AND PROCEDURES FOR USE WITHIN THE CONNECTICUT DEPARTMENT OF CORRECTION

DECIPHERING MY MYELOMA LAB RESULTS

DIRECTORATE of LABORATORY MEDICINE

Hematology Morphology Critique

Presents: Insider tips for the life insurance medical exam. Know what they are testing for--and how to get the best results.

Immunoassay. Product Portfolio. Part of the IDS group

Routine Investigations for Liver Disease a guide

HealthEast Medical Laboratory

1.5 Function of analyte For albumin, see separate entry. The immunoglobulins are components of the humoral arm of the immune system.

Laboratory Monitoring of Adult Hospital Patients Receiving Parenteral Nutrition

3. The Circulatory System

Your blood profiles explained

Biochemistry Validation Form

Summit Health Laboratory Tests. Test Range Guidelines Preventive Measures hour urine for cells, protein, calcium, and phosphate

Assessment of some biochemical tests in liver diseases

Prescribed Minimum Benefit treatment guidelines

Yvette Marie Miller, M.D. Executive Medical Officer American Red Cross October 20, th Annual Great Lakes Cancer Nursing Conference Troy, MI

Clinical Biochemistry

HEALTHWAY SCREENING & WELLNESS CENTRE - HEALTH SCREENING PACKAGES

LABORATORY 3: Microscopic Urinalysis

CHAPTER 14: CARDIOVASCULAR SYSTEM: BLOOD. 1. Describe blood according to its tissue type and major functions.

I ALBP Albumin BCP X X19) X 19)

Evaluation of abnormal LFT in the asymptomatic patient. Son Do, M.D. Advanced Gastroenterology Vancouver, WA

Young fetus: site of hematopoiesis together with the liver and bone marrow. Hgb WBC > < Plt Hct. Retic =

Thibodeau: Anatomy and Physiology, 5/e. Chapter 17: Blood

Making Sense of Blood Work in Greyhounds. By William E. Feeman III, DVM, C. Guillermo Couto, DVM, diplomate ACVIM, M. Cristina Iazbik, DVM

Transcription:

ALBUMIN 33 46 g/l ALK PHOSPHATASE Up to 11 months Male 133 426 U/L Female 196 553 U/L 11+ months 2 years Male 133 287 U/L Female 196 510 U/L 2+ 8 years Male 133 287 U/L Female 196 426 U/L 8+ 11 years Male 133 340 U/L Female 172 510 U/L 11+ 15 years Male 133 468 U/L Female 100 426 U/L 15+ 17 years Male 60 340 U/L Female 60 152 U/L 17+ 18 years Male 60 162 U/L Female 60 152 U/L 18+ 19 years Male 60 162 U/L Female 40 130 U/L Adult 30 110 U/L ALPHA 1 ANTITRYPSIN 0.88 1.74 g/l ALT (SGPT) 4 43 U/L AMYLASE 27 110 U/L AMYLASE URINE Random up to 350 U/L Per 24 hours up to 440 U/d ANDROSTENEDIONE Male 2.1 10.8 nmol/l Female 1.2 13.7 nmol/l ANION GAP with K + 10 20 mmol/l no K + 10 16 mmol/l QAP0037 Effective: 3-Dec-12 Page 1 of 11

ANTI DNA < 20 IU/mL Borderline 20 25 IU/mL Positive > 25 IU/mL AST (SGOT) 6 42 U/L ASO less than 116 KU/L BILIRUBIN TOTAL Greater than 5 days 3 18 mol/l 2 5 days 68 200 mol/l Less than 2 days 100 120 mol/l BILIRUBIN DIRECT 0 5 mol/l CALCIUM Greater than 18 years 2.15 2.60 mmol/l 11 days 18 years 2.20 2.70 mmol/l Up to 10 days 1.90 2.60 mmol/l CALCIUM URINE Random 1.7 5.0 mmol/l 24 Hours 1.2 6.2 mmol/d CARBAMAZEPINE 17 51 mol/l CA125 0-35 U/mL CERULOPLASMIN 200 640 mg/l CHLORIDE 95 108 mmol/l CHLORIDE URINE Random 15 250 mmol/l 24 Hour 110 250 mmol/d CHOLESTEROL Less than 29 years Target less than 4.60 mmol/l Greater than 29 years Target less than 5.20 mmol/l CHOLESTEROL/HDL RATIO If Risk Target Low Risk less than 6.0 Moderate Risk less than 5.0 High Risk less than 4.0 CK Male less than 210 U/L Female less than 170 U/L CO2 21 31 mmol/l COMPLEMENT C3 0.70 1.76 g/l COMPLEMENT C4 0.16 0.45 g/l hs CRP Low Risk less than 1.0 mg/l Average Risk 1.0 3.0 mg/l High Risk greater than 3.0 mg/l QAP0037 Effective: 3-Dec-12 Page 2 of 11

CORTISOL A.M. 185 624 nmol/l P.M. < 280 nmol/l Random Cannot be determined Free, Urine 24 Hour 138 524 nmol/d Total, Urine 24 Hour 440 1800 nmol/d C PEPTIDE 298 2350 pmol/l CREATININE Male (greater 10 years) 60 127 mol/l Female (greater 10 years) 60 115 mol/l 5 10 years 44 71 mol/l Less than 5 years less than 44 mol/l CREATININE URINE Random Male 5.0 13.0 mmol/l Random Female 3.0 11.0 mmol/l 24 Hour Male 7.0 20.0 mmol/d 24 Hour Female 4.0 16.0 mmol/d CREATININE CLEARANCE 1.25 1.92 ml/s DHEA S Male less than 14.1 mol/l Female less than 11.0 mol/l DIGOXIN 0.6 2.6 nmol/l DILANTIN (PHENYTOIN) 40 80 mol/l ESTRADIOL ETHYL ALCOHOL Non Pregnant Female: Mid Follicular 99 448 pmol/l Mid Cycle Peak 350 1590 pmol/l Mid Luteal 180 1068 pmol/l Post Menopausal 0 147 pmol/l Male 0 172 pmol/l None Detected FERRITIN Male 25 200 g/l Female 11 145 g/l Newborn 5 100 g/l FOLATE ERCS (RBC FOLATE) greater than 829 nmol/l QAP0037 Effective: 3-Dec-12 Page 3 of 11

FSH Female: Mid Follicular 3.9 8.8 IU/L Mid Cycle Peak 4.5 22.5 IU/L Mid Luteal 1.8 5.1 IU/L Post Menopausal 16.7 113.6 IU/L Male 1.3 19.3 IU/L GAMMA GT (GGT) Male 5 50 U/L Female 5 40 U/L GASTRIN 13 115 ng/l GLUCOSE FASTING New Born 3 years 2.5 5.0 mmol/l Children (3 12 years) 2.8 6.1 mmol/l Adolescent (13 18 years) 3.3 6.1 mmol/l 19 years Adult 3.3 6.0 mmol/l GLUCOSE RANDOM 3.3 7.8 mmol/l GLUCOSE PC 2 Hour 3.30 7.80 mmol/l GLUCOSE CHALLENGE Fasting 75 g Load 3.3 6.0 mmol/l 2 Hour 3.3 7.7 mmol/l GLUCOSE CHALLENGE 50 G LOAD (GESTATIONAL) (GESTATIONAL SCREEN) 1 Hour 3.3 7.8 mmol/l GLUCOSE TOLERANCE 75 G LOAD (GESTATIONAL) (GESTATIONAL) FBS 3.3 5.3 mmol/l 1 Hour 3.3 10.6 mmol/l 2 Hour 3.3 8.9 mmol/l 100 G LOAD (GESTATIONAL) FBS (> 18 years) 3.3 6.1 mmol/l FBS (up to 18 years) 2.8 6.1 mmol/l 1 Hour 3.3 10.6 mmol/l 2 Hour 3.3 9.2 mmol/l 3 Hour 3.3 8.1 mmol/l GLYCOSYLATED HAEMOGLOBIN (HbA1C) 0.040 0.060 GROWTH HORMONE Male 0 1.0 g/l Female 0 4.0 g/l HAPTOGLOBIN 0.40 1.90 g/l QAP0037 Effective: 3-Dec-12 Page 4 of 11

hcg Female, Non Pregnant less than 5 IU/L Female, Pregnant: 1st week 5 50 IU/L 2nd week 40 300 IU/L 3rd week 100 1000 IU/L 1st trimester 10000 200,000 IU/L (PEAK) 2nd trimester 3000 50,000 IU/L 3rd trimester 1000 50,000 IU/L Male less than 2 IU/L HDL Target greater than 1.29 mmol/l HOMOCYSTEINE 5.0 15.4 mol/l H. PYLORI less than 15 U/mL HEPATITIS Borderline Positive 15 30 U/mL Positive > 30 U/mL HIGH SENSITIVITY CRP Low Risk less than 1.0 mg/l (hs CRP) Average Risk 1.0 3.0 mg/l High Risk greater than 3.0 mg/l IMMUNOGLOBULINS Greater than 16 Years: IgG 5.64 17.65 g/l IgA 0.85 3.85 g/l IgM 0.45 2.50 g/l IgE 0 432 g/l PEDIATRIC IMMUNOGLOBULINS Age IgG (g/l) IgA (g/l) IgM (g/l) 0 6 months 1.50 4.70 0.20 1.30 0.30 0.60 6 mos 1 year 1.40 10.30 0.20 1.30 0.30 1.60 1 2 years 2.80 9.60 0.20 1.10 0.30 1.50 2 5 years 3.70 15.00 0.30 2.00 0.20 2.20 5 10 years 4.40 15.50 0.50 2.30 0.30 1.70 10 16 years 4.50 14.40 0.40 2.40 0.40 2.00 INSULIN Fasting 13 161 pmol/l 2-hour (post challenge) Cannot be determined Random Cannot be determined QAP0037 Effective: 3-Dec-12 Page 5 of 11

IONIZED CALCIUM 1.15 1.35 mmol/l IRON 10 26 mol/l IRON SATURATION 0.25 0.50 LD 76 200 U/L LDL If clinically determined risk is: Target for LDL-C Low reduce by 50% Moderate or High < 2.0 or reduce by 50 % LH Female: Mid Follicular 2.1 10.9 IU/L Mid Cycle 19.2 103.0 IU/L Mid Luteal 1.2 12.9 IU/L Post Menopausal 10.9 58.6 IU/L Male 1.2 8.6 IU/L LITHIUM 0.6 1.2 mmol/l May reflect acute toxicity 1.5 mmol/l LEAD BLOOD Up to 16 years up to 0.48 mol/l Male (17 yrs and above) up to 1.00 mol/l Female (17 45 yrs) up to 0.48 mol/l Female (> 45 yrs) up to 1.00 mol/l LIPASE 13 80 U/L MAGNESIUM 0.65 1.05 mmol/l MICROALBUMIN Random less than 15 mg/l 24 Hour less than 21 mg/d MICROALBUMIN/ Male less than 2.0 CREATININE RATIO Female less than 2.8 PHENOBARBITAL 65 172 mol/l PHOSPHATE 0.80 1.52 mmol/l PHOSPHATE URINE Random 8.7 28.0 mmol/l 24 Hour 13 42 mmol/l POTASSIUM 3.5 5.2 mmol/l POTASSIUM URINE Random 17 80 mmol/l 24 Hour 25 120 mmol/d QAP0037 Effective: 3-Dec-12 Page 6 of 11

PROGESTERONE Male 0.3 2.7 nmol/l Female, Non Pregnant: Mid Follicular 1.0 4.8 nmol/l Mid Luteal 16.4 59.0 nmol/l Post Menopausal < 0.3 2.5 nmol/l Female, Pregnant: First Trimester 15.0 161.4 nmol/l Second Trimester 61.7 144.0 nmol/l PROLACTIN Male 2.6 13.1 g/l Female 3.3 26.7 g/l PROTEIN SYNOVIAL FLUID 10 30 g/l PROTEIN TOTAL 60 82 g/l PROTEIN URINE RANDOM 0 0.15 g/l PROTEIN URINE 24 HOUR 0 0.2 g/d PSA TOTAL less than 4.00 g/l PSA FREE less than 0.934 For Total PSA between 4 and 10 g/l, a Free/Total PSA ratio of < 0.25 is associated with an increased risk of prostate cancer. PTH 1.3 8.2 pmol/l RHEUMATOID FACTOR (RF) less than 20 IU/mL RUBELLA Non Immune less than 5 IU/mL Inconclusive 5 10 IU/mL Immune greater than 10 IU/mL SODIUM 135 146 mmol/l SODIUM URINE Random 20 230 mmol/l 24 hour 40 220 mmol/d T3 FREE 2.9 6.0 pmol/l T3 TOTAL 1.3 2.5 nmol/l T4 FREE 7.2 21.0 pmol/l OSTERONE, TOTAL Female 0.4 2.6 nmol/l QAP0037 Effective: 3-Dec-12 Page 7 of 11

BIOCHEMISTRY DEPARTMENT Male 6.0 27.0 nmol/l OSTERONE, FREE Male 15.6 146 pmol/l Female 0 14.2 pmol/l THEOPHYLLINE 55 110 mol/l THYROGLOBULIN < 45 pmol/l TIBC 45 63 mol/l TRIGLYCERIDES Up to 18 years less than 1.20 mmol/l Over 18 years less than 1.71 mmol/l TSH, SENSITIVE (S TSH) 0.3 5.6 miu/l UIBC 19 51 mol/l URATE (URIC ACID) Male 180 450 mol/l Female 120 400 mol/l URATE (URIC ACID) URINE Random 1.0 3.0 mmol/l 24 hour 1.50 4.50 mmol/d URATE SYNOVIAL FLUID 200 480 mol UREA (BUN) 3.0 8.2 mmol/l VANILMANDELIC ACID (VMA URINE) 10.0 40.0 mol/d VALPROIC ACID 347 693 mol/l VITAMIN B12 Deficient < 107 pmol/l Indeterminate 107 133 pmol/l Sufficient > 133 pmol/l VITAMIN D (25 HYDROXY) Ideal 75 200 nmol/l Toxic > 250 nmol/l QAP0037 Effective: 3-Dec-12 Page 8 of 11

HEMATOLOGY DEPARTMENT BLOOD FILM (DIFFERENTIAL) Relative Segmented Neutros 0.40 0.75 Frac of 1 Band Neutros 0.00 0.05 Frac of 1 Lymphocytes 0.20 0.45 Frac of 1 Monocytes 0.02 0.13 Frac of 1 Eosinophils 0.01 0.06 Frac of 1 Basophils 0.00 0.01 Frac of 1 Absolute Neutros 2.0 7.5 x10 9 /L Lymphocytes 1.1 3.3 x10 9 /L Monocytes 0.0 0.8 x10 9 /L Eosinophils 0.0 0.5 x10 9 /L Basophils 0.0 0.2 x10 9 /L D-DIMER < 500 µg/ml ERCS (RBC) Male 4.5 6.5 x10 12 /L Female 3.8 5.8 x10 12 /L ESR. (SED. RATE) Male: Female: 17 50 years 0 10 mm > 50 years 0 14 mm 17 50 years 0 12 mm > 50 years 0 20 mm FIBRINOGEN 1.5 4.0 g/l HEMATOCRIT (PCV) Male 0.37 0.54 Frac of 1 Female 0.37 0.47 Frac of 1 HEMOGLOBIN Male 135 180 g/l Female 115 165 g/l LKCS (WBC) 4.0 11.0 x10 9 /L MCH 27.0 32.0 pg MCHC 320 360 g/l MCV 80 97 f/l RETICULOCYTE COUNT 25 85 x10 9 /L THROMBOCYTES (Platelets) 150 400 x10 9 /L RDW 11 14.5 INR 0.8 1.2 PTT 26 39 Seconds QAP0037 Effective: 3-Dec-12 Page 9 of 11

MISCELLANEOUS URINALYSIS (Routine) Bilirubin Blood Glucose Ketones Leukocytes Esterase Nitrite ph 5 9 Protein Specific Gravity 1.005 1.030 Urobilinogen 3.2 16 mol/l (Microscopic) WBC 0 9 p/ul RBC 0 5 p/ul Epithelials 0 9 p/ul Epithelials Non-Squamous 0 2 p/ul Casts (hyaline) 0 2 p/ul Mucous 0 264 p/ul Amorphous Phosphates 0 6 p/ul Amorphous Urates 0 6 p/ul Crystals Calcium Oxalate 0 6 p/ul Urate 0 6 p/ul Triple Phosphate 0-6 p/ul Bacteria 0-75 p/ul QAP0037 Effective: 3-Dec-12 Page 10 of 11

PEDIATRIC HEMATOLOGY S BIRTH 1 WK 2 MO 3 11 MO 1 5 YR 6 10 YR 11 14 YR TOTAL LKCS 20 40 5 21 5 15 5 12 4 11 4 11 x10 9 /L NEUTS 6 26 1.5 10 1.5 8.5 1.5 8.5 1.5 8 2 7.5 x10 9 /L BANDS 0 0.8 0 0.8 0 0 0 0 x10 9 /L LYMPHS 2 11 2 17 4 10.5 2 8 1.5 7 1.1 3.3 x10 9 /L MONOS 0.4 3.1 0.2 2.4 0.05 1.1 0 0.8 0 0.8 0 0.8 x10 9 /L EOS 0.02 0.85 0.07 1 0.05 0.7 0.02 0.5 0 0.5 0 0.5 x10 9 /L BASOS 0 0.2 0 0.2 0 0.2 0 0.2 0 0.2 0 0.2 x10 9 /L ERCS 3.5 6 3.5 5.5 3.5 5 4 5 4.5 5.5 4.5 5.5 x10 12 /L HB 150 250 115 180 100 140 110 140 120 160 125 170 g/l HCT 0.46 0.74 0.35 0.54 0.30 0.42 0.33 0.42 0.36 0.48 0.39 0.50 frac of 1 MCV 95 120 77 115 70 86 80 94 80 94 80 100 fl MCH 33 39 24 34 24 31 24 31 24 31 24 31 pg MCHC 320 360 320 360 320 360 320 360 320 360 320 360 g/l RETICS 200 300 10 100 10 100 10 100 10 100 10 100 x109/l PLATELETS 150 400 150 400 150 400 150 400 150 400 150 400 x109/l QAP0037 Effective: 3-Dec-12 Page 11 of 11